247 related articles for article (PubMed ID: 8381349)
21. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
Kempkes B; Pawlita M; Zimber-Strobl U; Eissner G; Laux G; Bornkamm GW
Virology; 1995 Dec; 214(2):675-9. PubMed ID: 8553575
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
Zimber-Strobl U; Strobl LJ; Meitinger C; Hinrichs R; Sakai T; Furukawa T; Honjo T; Bornkamm GW
EMBO J; 1994 Oct; 13(20):4973-82. PubMed ID: 7957063
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
Wu DY; Kalpana GV; Goff SP; Schubach WH
J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
[TBL] [Abstract][Full Text] [Related]
26. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site.
Jansson A; Johansson P; Li S; Rymo L
J Gen Virol; 2007 Jul; 88(Pt 7):1887-1894. PubMed ID: 17554019
[TBL] [Abstract][Full Text] [Related]
27. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
28. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
Cordier-Bussat M; Calender A; Vuillaume M; Bornkamm GW; Lenoir GM
Virus Res; 1993 Jan; 27(1):55-69. PubMed ID: 8383394
[TBL] [Abstract][Full Text] [Related]
30. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
32. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD
J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808
[TBL] [Abstract][Full Text] [Related]
33. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
Hsieh JJ; Hayward SD
Science; 1995 Apr; 268(5210):560-3. PubMed ID: 7725102
[TBL] [Abstract][Full Text] [Related]
34. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
Fuentes-Pananá EM; Swaminathan S; Ling PD
J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
[TBL] [Abstract][Full Text] [Related]
36. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
37. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
Sung NS; Kenney S; Gutsch D; Pagano JS
J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
[TBL] [Abstract][Full Text] [Related]
39. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
Ricksten A; Olsson A; Andersson T; Rymo L
Nucleic Acids Res; 1988 Sep; 16(17):8391-410. PubMed ID: 2843816
[TBL] [Abstract][Full Text] [Related]
40. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
Waltzer L; Logeat F; Brou C; Israel A; Sergeant A; Manet E
EMBO J; 1994 Dec; 13(23):5633-8. PubMed ID: 7988560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
